Associations between triglyceride glucose-body mass index and cardiovascular, renal, hepatic and bone biomarkers in patients with type 2 diabetes: a single-center, cross-sectional study.

Front Endocrinol (Lausanne) · 2025 · PMC12463613 · PMID 41019332

Europe PMC DOI

hedged sentences

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

an increasing trendP < 0.0001actually significant

3.7 Hepatic characteristics of TyG-BMI subgroup in T2D patients For hepatic risk, the aspartate aminotransferase (AST) level had an increasing trend across TyG-BMI Q1 to Q4 subgroups ( P < 0.0001) ( Figure 7 ; Table 2 ).

also in 63,971 other papers

highly significantP < 0.0001actually significant

The median levels are about 12.40 ng/mL in Q1, 12.06 ng/mL in Q2, 11.54 ng/mL in Q3, and 10.45 ng/mL in Q4, with highly significant differences between the quartiles ( P < 0.0001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.